Blog

Testosterone & Anti-Aging Therapy

Sterile & Non-Sterile Compounding

Clinical Laboratory Analysis

Dietary Supplements & Nutraceuticals

Consulting Services

Anti-Aging News

Injectable BPC-157 vs. Pentadecapeptide Arginate
The Next Evolution in Regenerative Peptide Therapy When it comes to advanced recovery and regenerative medicine, few compounds have generated as much interest as BPC-157. Known for its powerful effects on muscle, tendon, ligament, and gastrointestinal healing, BPC-157...
Testosterone Optimization Therapy (TOT) and Fertility Can Coexist
In the constantly evolving landscape of male hormone optimization, few clinical challenges are as delicate as maintaining fertility while undergoing testosterone optimization therapy (TOT). Conventional wisdom and physiology tell us that exogenous testosterone...
FDA’s Shift on Testosterone: A Long-Awaited Reversal
The U.S. Food and Drug Administration (FDA) has once again reversed course on a major drug safety issue—this time, on testosterone therapy. In response to findings from the TRAVERSE clinical trial and post market ambulatory blood pressure (ABPM) studies, the FDA is...
Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications
The much anticipated announcement of the Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications effective 15 November 2024.  When Covid began the DEA needed to find a solution to allow patients access to care...
Injectable BPC-157 vs. Pentadecapeptide Arginate
The Next Evolution in Regenerative Peptide Therapy When it comes to advanced recovery and regenerative medicine, few compounds have generated as much interest as BPC-157. Known for its powerful effects on muscle, tendon, ligament, and gastrointestinal healing, BPC-157...
Testosterone Optimization Therapy (TOT) and Fertility Can Coexist
In the constantly evolving landscape of male hormone optimization, few clinical challenges are as delicate as maintaining fertility while undergoing testosterone optimization therapy (TOT). Conventional wisdom and physiology tell us that exogenous testosterone...
FDA’s Shift on Testosterone: A Long-Awaited Reversal
The U.S. Food and Drug Administration (FDA) has once again reversed course on a major drug safety issue—this time, on testosterone therapy. In response to findings from the TRAVERSE clinical trial and post market ambulatory blood pressure (ABPM) studies, the FDA is...
Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications
The much anticipated announcement of the Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications effective 15 November 2024.  When Covid began the DEA needed to find a solution to allow patients access to care...